risedronic acid


Mega Lifesciences


Zuellig Pharma
Concise Prescribing Info
Risedronate Na
Treatment & prevention of osteoporosis in postmenopausal women. Treatment to increase bone mass in men w/ osteoporosis.
Dosage/Direction for Use
Adult 1 tab once wkly taken on the same day each wk.
Should be taken on an empty stomach: Take before breakfast or at least 30 min before the 1st food/drink/med of the day. Take w/ a full glass (≥120 mL) of plain water while in an upright position. Do not lie down for at least 30 min after taking. Swallow whole, do not chew/crush/suck.
Hypersensitivity. Hypocalcaemia. Severe renal impairment (CrCl <30 mL/min). Pregnancy & lactation.
Special Precautions
History of oesophageal disorders. Patients w/ inability to remain in an upright position for at least 30 min after taking Residron. Active or recent oesophageal or upper GI problems. Treat hypocalcemia & other bone & mineral metabolism disturbances prior to therapy. Consider dental exam w/ appropriate preventive dentistry prior to treatment. Dental surgery. Childn & adolescents.
Adverse Reactions
HTN, headache, rash, increased serum PTH levels, diarrhea, nausea, constipation, abdominal pain, dyspepsia, UTI, arthralgia, back pain, infection.
Drug Interactions
Decreased absorption w/ antacids or mineral supplements containing divalent cations (eg, Al, Ca, Mg). Decreased levels/effects by NSAIDs & aminoglycosides. Increase levels/effects of phosphate supplements.
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BA07 - risedronic acid ; Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.
Residron FC tab 35 mg
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in